Literature DB >> 16838391

Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease.

D Beddy1, J Mulsow, R W G Watson, J M Fitzpatrick, P R O'Connell.   

Abstract

BACKGROUND: Connective tissue growth factor (CTGF) stimulates fibroblast proliferation and extracellular matrix production. Fibroblasts may initiate stricture formation in Crohn's disease through overexpression of CTGF. Stricturing that occurs in patients with Crohn's disease after treatment with anti-tumour necrosis factor (TNF) alpha may be due to dysregulation of CTGF homeostasis. The aim of this study was to examine CTGF expression and regulation in fibroblasts isolated from patients with Crohn's disease.
METHODS: Fibroblasts were isolated by a primary explant technique from serosal biopsies of strictured segments of bowel in eight patients undergoing resection for Crohn's disease and from normal colon in seven patients having resection for benign or malignant colorectal disease. Cells were stimulated with transforming growth factor (TGF) beta and TNF-alpha. CTGF protein and mRNA expression were measured by western blotting and real-time polymerase chain reaction respectively.
RESULTS: Mean(s.d.) CTGF protein expression in strictured Crohn's fibroblasts was higher than that in normal fibroblasts (56.5(9.7) versus 17.0(10.0) respectively; P = 0.011). In normal and strictured Crohn's fibroblasts, culture with TGF-beta increased CTGF protein and mRNA expression. Co-culture of normal fibroblasts with TNF-alpha suppressed TGF-beta-stimulated CTGF expression.
CONCLUSION: : Increased expression of CTGF in strictured Crohn's fibroblasts underlies its role in fibrosis. TNF-alpha suppresses fibrosis by downregulating fibroblast CTGF expression, an effect that may be lost following anti-TNF-alpha treatment, thereby promoting stricture formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838391     DOI: 10.1002/bjs.5431

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

1.  Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats.

Authors:  Dov Wengrower; Giuliana Zanninelli; Giovanni Latella; Stefano Necozione; Issa Metanes; Eran Israeli; Joseph Lysy; Mark Pines; Orit Papo; Eran Goldin
Journal:  Can J Gastroenterol       Date:  2012-01       Impact factor: 3.522

2.  Outcome and complications of endoscopic balloon dilatations in various types of ileocaecal and colonic stenosis in patients with Crohn's disease.

Authors:  Alexander F Hagel; Anna Hahn; Wolfgang Dauth; Klaus Matzel; Peter C Konturek; Markus F Neurath; Martin Raithel
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

Review 3.  Prof Ronan O'Connell Festschrift: Stricture pathogenesis in Crohn's disease-the role of intestinal fibroblasts.

Authors:  Jürgen Mulsow
Journal:  Ir J Med Sci       Date:  2018-07-18       Impact factor: 1.568

Review 4.  Role of Rho kinase signal pathway in inflammatory bowel disease.

Authors:  Yuan Huang; Shiyu Xiao; Quanhang Jiang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis.

Authors:  Hao Ding; Hui-Zhong Gan; Wen-Jie Fan; Li-Yu Cao; Jian-Ming Xu; Qiao Mei
Journal:  Dig Dis Sci       Date:  2014-10-08       Impact factor: 3.199

6.  Simvastatin attenuates intestinal fibrosis independent of the anti-inflammatory effect by promoting fibroblast/myofibroblast apoptosis in the regeneration/healing process from TNBS-induced colitis.

Authors:  Yosuke Abe; Mitsuyuki Murano; Naoko Murano; Eijiro Morita; Takuya Inoue; Ken Kawakami; Kumi Ishida; Takanori Kuramoto; Kazuki Kakimoto; Toshihiko Okada; Ken Narabayashi; Eiji Umegaki; Kazuhide Higuchi
Journal:  Dig Dis Sci       Date:  2011-09-11       Impact factor: 3.199

7.  Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease.

Authors:  Phyllissa Schmiedlin-Ren; Laura J Reingold; Christopher S Broxson; Ahren C Rittershaus; Josh S Brudi; Jeremy Adler; Scott R Owens; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

8.  Effect of CTRP3 on activation of adventitial fibroblasts induced by TGF-β1 from rat aorta in vitro.

Authors:  Shaohui Lin; Shaojun Ma; Ping Lu; Wenwei Cai; Yi Chen; Jing Sheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  CCN5 expression in mammals : I. Embryonic and fetal tissues of mouse and human.

Authors:  Jennifer A Jones; Mark R Gray; Beatriz Enes Oliveira; Manuel Koch; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-20       Impact factor: 5.782

Review 10.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.